3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Gynecologic
1
Genitourinary
1
Conditions
Ovarian Neoplasms
12
Breast Neoplasms
10
Endometrial Neoplasms
7
Pancreatic Neoplasms
5
Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Neoplasms by Site
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Inflammation
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Neoplasms
1
Interventions
palbociclib
1
montelukast
1
Tablets
1
Probiotics
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
palbociclib
×
Gynecologic
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled